Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio.
Versluis J, In 't Hout FE, Devillier R, van Putten WL, Manz MG, Vekemans MC, Legdeur MC, Passweg JR, Maertens J, Kuball J, Biemond BJ, Valk PJ, van der Reijden BA, Meloni G, Schouten HC, Vellenga E, Pabst T, Willemze R, Löwenberg B, Ossenkoppele G, Baron F, Huls G, Cornelissen JJ. Versluis J, et al. Among authors: devillier r. Leukemia. 2017 Jan;31(1):26-33. doi: 10.1038/leu.2016.183. Epub 2016 Jun 24. Leukemia. 2017. PMID: 27416910 Free article.
GVHD prophylaxis with post-transplant cyclophosphamide results in lower incidence of GVHD and allows faster immunosuppressive treatment reduction compared to antithymocyte globulin in 10/10 HLA-matched unrelated allogeneic hematopoietic cell transplantation.
Dachy F, Furst S, Calmels B, Pagliardini T, Harbi S, Bouchacourt B, Calleja A, Lemarie C, Collignon A, Morel G, Legrand F, Bekrieva E, Granata A, Weiller PJ, Chabannon C, Schiano JM, Vey N, Blaise D, Devillier R. Dachy F, et al. Among authors: devillier r. Bone Marrow Transplant. 2023 Nov;58(11):1179-1181. doi: 10.1038/s41409-023-02033-0. Epub 2023 Aug 9. Bone Marrow Transplant. 2023. PMID: 37558780 No abstract available.
Correction: Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working party.
Santoro N, Mooyaart JE, Devillier R, Koc Y, Vydra J, Castagna L, Gülbas Z, Martin JD, Araujo MC, Kulagin A, Arat M, Arroyo CH, Martelli MP, Di Ianni M, Hoogenboom JD, de Wreede LC, Ruggeri A, Chabannon C. Santoro N, et al. Among authors: devillier r. Bone Marrow Transplant. 2023 Jan;58(1):119-120. doi: 10.1038/s41409-022-01855-8. Bone Marrow Transplant. 2023. PMID: 36517566 No abstract available.
IDALLO study: A retrospective multicenter study of the SFGM-TC evaluating the efficacy and safety of ivosidenib in relapsed IDH1-mutated AML after allogeneic hematopoietic cell transplantation.
Caillet A, Simonet-Boissard M, Forcade E, Robin M, Rubio MT, Couturier MA, Srour M, Maillard N, Devillier R, Huynh A, Bourhis JH, Simand C, Chantepie S, Boisson C, Kroemer M, Deconinck E, Berceanu A. Caillet A, et al. Among authors: devillier r. Hemasphere. 2024 Mar 10;8(3):e44. doi: 10.1002/hem3.44. eCollection 2024 Mar. Hemasphere. 2024. PMID: 38469458 Free PMC article. No abstract available.
Impact of antithymocyte globulin doses in reduced intensity conditioning before allogeneic transplantation from matched sibling donor for patients with acute myeloid leukemia: a report from the acute leukemia working party of European group of Bone Marrow Transplantation.
Devillier R, Labopin M, Chevallier P, Ledoux MP, Socié G, Huynh A, Bourhis JH, Cahn JY, Roth-Guepin G, Mufti G, Desmier D, Michallet M, Fegueux N, Ciceri F, Baron F, Blaise D, Nagler A, Mohty M. Devillier R, et al. Bone Marrow Transplant. 2018 Apr;53(4):431-437. doi: 10.1038/s41409-017-0043-y. Epub 2018 Jan 12. Bone Marrow Transplant. 2018. PMID: 29330391 Free article.
Impact of Adding Antithymocyte Globulin to Posttransplantation Cyclophosphamide in Haploidentical Stem-Cell Transplantation.
El-Cheikh J, Devillier R, Dulery R, Massoud R, Al Chami F, Ghaoui N, Moukalled N, Pagliardini T, Marino F, Malard F, Bazarbachi AH, Mohty R, Bazarbachi A, Castagna L, Mohty M, Blaise D. El-Cheikh J, et al. Among authors: devillier r. Clin Lymphoma Myeloma Leuk. 2020 Sep;20(9):617-623. doi: 10.1016/j.clml.2020.04.003. Epub 2020 Apr 20. Clin Lymphoma Myeloma Leuk. 2020. PMID: 32457025
Reduced-toxicity conditioning prior to allogeneic stem cell transplantation improves outcome in patients with myeloid malignancies.
Oudin C, Chevallier P, Furst S, Guillaume T, El Cheikh J, Delaunay J, Castagna L, Faucher C, Granata A, Devillier R, Chabannon C, Esterni B, Vey N, Mohty M, Blaise D. Oudin C, et al. Among authors: devillier r. Haematologica. 2014 Nov;99(11):1762-8. doi: 10.3324/haematol.2014.105981. Epub 2014 Aug 1. Haematologica. 2014. PMID: 25085356 Free PMC article.
Stem cell transplantation in severe congenital neutropenia: an analysis from the European Society for Blood and Marrow Transplantation.
Fioredda F, Iacobelli S, van Biezen A, Gaspar B, Ancliff P, Donadieu J, Aljurf M, Peters C, Calvillo M, Matthes-Martin S, Morreale G, van 't Veer-Tazelaar N, de Wreede L, Al Seraihy A, Yesilipek A, Fischer A, Bierings M, Ozturk G, Smith O, Veys P, Ljungman P, Peffault de Latour R, Sánchez de Toledo Codina J, Or R, Ganser A, Afanasyev B, Wynn R, Kalwak K, Marsh J, Dufour C; Severe Aplastic Anemia the Inborn Error, and the Pediatric Disease Working Parties of the European Society for Blood and Bone Marrow Transplantation (EBMT) and Stem Cell Transplant for Immunodeficiencies in Europe (SCETIDE). Fioredda F, et al. Blood. 2015 Oct 15;126(16):1885-92; quiz 1970. doi: 10.1182/blood-2015-02-628859. Epub 2015 Jul 16. Blood. 2015. PMID: 26185129 Free article. Clinical Trial.
105 results